GROWTH OPPORTUNITIES IN DRUG DISCOVERY PLATFORMS, IMAGING TOOLS, GENE AND IMMUNOTHERAPY FOR CANCER, AUTOIMMUNE AND INFECTIOUS DISEASES

GROWTH OPPORTUNITIES IN DRUG DISCOVERY PLATFORMS, IMAGING TOOLS, GENE AND IMMUNOTHERAPY FOR CANCER, AUTOIMMUNE AND INFECTIOUS DISEASES

RELEASE DATE
13-Nov-2020
REGION
Global
Research Code: D759-00-1A-00-00
SKU: HC03355-GL-TA_24937
$950.00
In stock
SKU
HC03355-GL-TA_24937
$950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) consists of insights across phosphoproteome and ultrasound-based drug-discovery, drug nanoformulations, drugs for antimicrobial resistance, immunotherapy for autoimmune diseases, gene therapy for phenylketonuria. Further, it contains enabling technologies such as peptide hydrogel technology for cell culture, microfluidic bioprocessing, nano biopolymer-based fluorescent dyes for therapeutic imaging, neuroimaging technologies as well as diagnostic for COVID-19, neurodegenerative disorders and mental health.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Phosphoproteomics, antimicrobial resistance, hydrogel, regenerative medicine, nanoformulation, nanopolymers, bioimaging probe, fluorescent nanoparticle, autoimmune diseases, ultrasound, gas bubble-based drug delivery, peptide vaccines, microfluidic technology, AI-based genomic platform, optogenetics, cell-free DNA, diagnosis, brain lesions, phenylketonuria, sarcoma, Breath based diagnostic, COVID-19, mental health, CRISPR-based diagnostic, small molecular inhibitor, leukaemia, multiple myeloma, complete blood count, neurogenerative disorders, protein misfolding, Alzheimer's disease diagnosis, microfluidic, point of care, inflammatory bowel disease, bioreactor, bioprocessing

Table of Contents

INNOVATIONS IN LIFE SCIENCES, HEALTH & WELLNESS

  • KINOMICA LTD., UK
  • GROWTH OPPORTUNITIES
  • INFEX THERAPEUTICS, UK
  • GROWTH OPPORTUNITIES
  • MANCHESTER BIOGEL, UK
  • GROWTH OPPORTUNITIES
  • BLUEBERRY THERAPEUTICS, UK
  • GROWTH OPPORTUNITIES
  • STREAM BIO LTD., UK
  • GROWTH OPPORTUNITIES
  • MIROBIO, UK
  • GROWTH OPPORTUNITIES
  • OXSONICS THERAPEUTICS LTD., UK
  • GROWTH OPPORTUNITIES
  • OXFORD VACMEDIX UK LIMITED, UK
  • GROWTH OPPORTUNITIES
  • ERBI BIOSYSTEMS, US
  • GROWTH OPPORTUNITIES
  • TRANSGENE SA, FRANCE
  • GROWTH OPPORTUNITIES
  • UNIVERSITY COLLEGE LONDON, UK
  • GROWTH OPPORTUNITIES
  • UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE, US
  • GROWTH OPPORTUNITIES
  • BRAINTALE, FRANCE
  • GROWTH OPPORTUNITIES
  • HOMOLOGY MEDICINES, US
  • GROWTH OPPORTUNITIES
  • NANOBIOTIX SA, FRANCE
  • GROWTH OPPORTUNITIES
  • KAROLINSKA INSTITUTE, SWEDEN
  • GROWTH OPPORTUNITIES
  • BREATHONIX, SINGAPORE
  • GROWTH OPPORTUNITIES
  • PSYOMICS, UK
  • GROWTH OPPORTUNITIES
  • STANFORD UNIVERSITY, US
  • GROWTH OPPORTUNITIES
  • CELLCENTRIC LTD., UK
  • GROWTH OPPORTUNITIES
  • SIGHT DIAGNOSTICS, ISRAEL
  • GROWTH OPPORTUNITIES
  • YUMANITY, US
  • GROWTH OPPORTUNITIES
  • ALECTOR, US
  • GROWTH OPPORTUNITIES
  • C2N DIAGNOSTICS, US
  • GROWTH OPPORTUNITIES
  • GENOMTEC, US
  • GROWTH OPPORTUNITIES
  • PREDICTIMMUNE LTD., UK
  • GROWTH OPPORTUNITIES

KEY CONTACTS

  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • LEGAL DISCLAIMER
Related Research
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) consists of insights across phosphoproteome and ultrasound-based drug-discovery, drug nanoformulations, drugs for antimicrobial resistance, immunotherapy for autoimmune diseases, gene therapy for phenylketonuria. Further, it contains enabling technologies such as peptide hydrogel technology for cell culture, microfluidic bioprocessing, nano biopolymer-based fluorescent dyes for therapeutic imaging, neuroimaging technologies as well as diagnostic for COVID-19, neurodegenerative disorders and mental health. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Phosphoproteomics, antimicrobial resistance, hydrogel, regenerative medicine, nanoformulation, nanopolymers, bioimaging probe, fluorescent nanoparticle, autoimmune diseases, ultrasound, gas bubble-based drug delivery, peptide vaccines, microfluidic technology, AI-based genomic platform, optogenetics, cell-free DNA, diagnosis, brain lesions, phenylketonuria, sarcoma, Breath based diagnostic, COVID-19, mental health, CRISPR-based diagnostic, small molecular inhibitor, leukaemia, multiple myeloma, complete blood count, neurogenerative disorders, protein misfolding, Alzheimer's disease diagnosis, microfluidic, point of care, inflammatory bowel disease, bioreactor, bioprocessing
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-1A-00-00
Is Prebook No
Ti Codes D759